Real world evidence: experience and lessons from China
- PMID: 29437644
- PMCID: PMC5797980
- DOI: 10.1136/bmj.j5262
Real world evidence: experience and lessons from China
Erratum in
-
Real world evidence: experience and lessons from China.BMJ. 2018 Apr 6;361:k1580. doi: 10.1136/bmj.k1580. BMJ. 2018. PMID: 29625964 Free PMC article. No abstract available.
Abstract
Xin Sun and colleagues discuss the development of real world evidence in Chinese healthcare and propose strategies to improve its quality and usefulness
Conflict of interest statement
Competing interests: We have read and understood BMJ policy on declaration of interests and declare that the study was supported by the National Natural Science Foundation of China (grant number 81590955; 71573183; 71704122), Thousand Youth Talents Plan of China (grant number D1024002), and The National Science Foundation for Post-doctoral Scientists of China (grant number 2016M602699). JJG is supported by the US Center of Medicaid and Medicare Services, PCORI, and unrestricted educational research grants sponsored by Novartis, AstraZeneca, Bristol-Myers Squibb, Janssen Ortho-McNeil, Roche, and Eli Lilly. None is related to this article.
Figures
References
-
- Charter R, Yeung A, Smith M, et al. The assessment of value for medical devices: using real world evidence (RWE) to quantify unmet needs in diabetes management. Value Health 2016;19:A703 10.1016/j.jval.2016.09.2046. - DOI
-
- US Food and Drug Administration. FDA’s Sentinel Initiative. 2016. https://www.fda.gov/Safety/FDAsSentinelInitiative/default.htm.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical